Robert Casey actually said...
Full disclosure of costs, rebates/discounts, etc. will almost guarantee all rebates and discounts (final expenditures) equalizing; companies will be unable to justify any price differences across populations.
Context
Warns against the implications of full cost transparency on drug pricing.
12/11/2017